scholarly article | Q13442814 |
P2093 | author name string | Snell N | |
P433 | issue | 1447 | |
P921 | main subject | ribavirin | Q421862 |
Lassa fever | Q706845 | ||
Lassa virus | Q1806636 | ||
P304 | page(s) | 432 | |
P577 | publication date | 1988-04-01 | |
P1433 | published in | The Practitioner | Q7758000 |
P1476 | title | Ribavirin therapy for lassa fever | |
P478 | volume | 232 |
Q40156113 | Arenavirus Genome Rearrangement for the Development of Live Attenuated Vaccines |
Q40285838 | Arenavirus nucleoproteins prevent activation of nuclear factor kappa B. |
Q37006773 | Arenavirus reverse genetics for vaccine development |
Q35487706 | Development of live-attenuated arenavirus vaccines based on codon deoptimization |
Q37546745 | Development of live-attenuated arenavirus vaccines based on codon deoptimization of the viral glycoprotein. |
Q39066377 | Inhibition of arenavirus by A3, a pyrimidine biosynthesis inhibitor. |
Q39144060 | Inhibition of multiplication of the prototypic arenavirus LCMV by valproic acid. |
Q35826274 | Self-association of lymphocytic choriomeningitis virus nucleoprotein is mediated by its N-terminal region and is not required for its anti-interferon function |
Q39462615 | The C-terminal region of lymphocytic choriomeningitis virus nucleoprotein contains distinct and segregable functional domains involved in NP-Z interaction and counteraction of the type I interferon response |
Q39625153 | Use of single-cycle infectious lymphocytic choriomeningitis virus to study hemorrhagic fever arenaviruses |
Search more.